Phase 1 Single Ascending and Multiple Ascending Dose Studies of Phosphodiesterase-9 Inhibitor E2027-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase 1 Single Ascending and Multiple Ascending Dose Studies of Phosphodiesterase-9 Inhibitor E2027

Published:2022-06-09 Issue:3 Volume:36 Page:200-207
ISSN:0893-0341
Container-title:Alzheimer Disease & Associated Disorders
language:en
Short-container-title:

Author:

Landry Ishani S.,Aluri Jagadeesh,Schuck Edgar,Ino Mitsuhiro,Horie Kanta,Boyd Peter,Reyderman Larisa,Lai Robert

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Gerontology,Clinical Psychology

Reference12 articles.

1. Clinical features of Lewy body dementia: insights into diagnosis and pathophysiology;Matar;J Neurol,2020

2. Clinical drug development for dementia with Lewy bodies: past and present;Lee;Expert Opin Investig Drugs,2019

3. Dementia with Lewy bodies;Mayo;Semin Neurol,2014

4. New evidence on the management of Lewy body dementia;Taylor;Lancet Neurol,2020

5. Pharmacological management of dementia with Lewy bodies;Hershey;Drugs Aging,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterase 9 localization in cytoplasm and nucleus: the gateway to selective targeting in neuroprotection?;Neural Regeneration Research;2024-07-10

2. The therapeutic potential of phosphodiesterase 9 (PDE9) inhibitors: a patent review (2018-present);Expert Opinion on Therapeutic Patents;2024-07-09

3. Insights into the management of Lewy body dementia: a scoping review;Annals of Medicine & Surgery;2024-01-03

4. An overview of phosphodiesterase 9 inhibitors: Insights from skeletal structure, pharmacophores, and therapeutic potential;European Journal of Medicinal Chemistry;2023-11

5. Lewy Body Dementia: An Overview of Promising Therapeutics;Current Neurology and Neuroscience Reports;2023-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3